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Supplementary Table 1. Diagnosis mapping: Global-PPS and GARPEC PPS data 
 
Global-PPS diagnosis Mapping to GARPEC diagnosis 
Acute Bronchitis or exacerbations of chronic bronchitis Proven or probable Viral LRTI
Antibiotic prescribed with documentation for which there is no above diagnosis group Other
Antimicrobial (e.g. erythromycin) prescribed for Prokinetic use Other
Bone/Joint Infections: Septic arthritis (including prosthetic joint), osteomyelitis Joint/Bone Infections
Cardiac or Vascular Surgery, endocarditis prophylaxis Prophylaxis for Surgical disease
CardioVascular System infections: endocarditis, endovascular prosthesis or device e.g pacemaker, vascular graft Cardiac Infections
Completely Unknown Indication Unknown
Drug is used as Medical Prophylaxis for MATERNAL risk factors e.g. maternal prolonged rupture of membranes Newborn Prophylaxis for Maternal Risk Factors 
Drug is used as Medical Prophylaxis for NEWBORN risk factors e.g. VLBW (Very Low Birth Weight) and IUGR (Intrauterine Growth Restriction) Newborn Prophylaxis for Newborn Risk Factors 
Drug is used as Medical Prophylaxis in general, without targeting a specific site, e.g. antifungal prophylaxis during imuunosuppression Prophylaxis for Medical problems
Fever in the Neutropaenic patient Febrile neutropenia/Fever
Fever syndrome in the non-neutropaenic Haematology, Oncolgy patient with no identified source of pathogen Febrile neutropenia/Fever
GI infections (salmonellosis, Campylobacter, parasitic, C.difficile, etc.) GI tract infections
Genito-Urinary Males + Prostatitis, epididymoorchitis, STD in men Other
Infection of the lymphatics as the primary source of infection e.g.suppurative lymphadenitis Lymphadenitis
Infections of the Central Nervous System Central Nervous System infections
Intra-abdominal sepsis including hepatobiliary, intra-abdominal abscess etc. Treatment for Surgical disease
Lower UTI Urinary Tract Infections 
Lung abscess including aspergilloma Other
Obstetric/Gynaecological infections, Sexual Transmitted Diseases (STD) in women Other
Pneumonia or LRTI (lower respiratory tract infections) Proven or probable Bacterial LRTI
Prophylaxis for CNS (neurosurgery, meningococcal) Prophylaxis for Medical problems
Prophylaxis for Ear, Nose, Throat (Surgical or Medical prophylaxis=SP/MP) Prophylaxis for Medical problems
Prophylaxis for Obstetric or Gynaecological surgery Prophylaxis for Surgical disease
Prophylaxis for eye operations Prophylaxis for Surgical disease
Prophylaxis for plastic or orthopaedic surgery (Bone or Joint) Prophylaxis for Surgical disease
Prophylaxis for urological surgery (SP) or recurrent Urinary Tract Infection (MP) Prophylaxis for Surgical disease
Pulmonary TB (Tuberculosis) Tuberculosis
Pulmonary surgery, prophylaxis for Respiratory pathogens Prophylaxis for Surgical disease
Pyrexia of Unknown Origin - Fever syndrome with no identified source or site of infection Pyrexia of Unknown Origin 
Sepsis, sepsis syndrome or septic shock with no clear anatomic site Sepsis
Skin and Soft Tissue: Cellulitis, wound including surgical site infection, deep soft tissue not involving bone e.g., infected pressure or diabetic ulcer, abscess Skin/Soft Tissue Infections 
Surgery of the Gastro-Intestinal tract, liver or biliary tree, GI prophylaxis in neutropaenic patients or hepatic failure Prophylaxis for Surgical disease
Therapy for Ear, Nose, Throat infections including mouth, sinuses, larynx Otitis media 
Upper Respiratory Tract viral Infections including influenza but not ENT Upper Respiratory Infections 
Upper UTI including catheter related urinary tract infection, pyelonephritis Urinary Tract Infections 
Bacteraemia with no clear anatomical site Sepsis
Endophthalmitis Other
Supplementary Table 2. WHO-EMLc: Access, Watch, and Reserve antibiotics 
 
Core Access antibiotics ATC code 
 Amoxicillin  J01CA04 
 Amoxicillin and clavulanic acid J01CR02 
 Ampicillin  J01CA01 
 Benzathine benzylpenicillin J01CE08 
 Benzylpenicillin J01CE01 
 Cefalexin J01DB01 
 Cefazolin J01DB04 
 Chloramphenicol J01BA01 
 Clindamycin J01FF01 
 Cloxacillin J01CF01 
 Doxycycline J01AA02 
 Gentamicin  J01GB03 
 Amikacin  J01GB06 
 Metronidazole J01XD01 
 Nitrofurantoin J01XE01 
 Phenoxymethylpenicillin  J01CE02 
 Procaine benzylpenicillin J01CE09 
 Spectinomycin  J01XX04 
 Sulfamethoxazole and trimethoprim  J01EE01 
Watch antibiotics  ATC code 
Anti-pseudomonal penicillins with beta-lactamase inhibitor  
     Piperacillin and tazobactam J01CR05 
Carbapenems or penems  
     Faropenem J01DI03 
     Imipenem and cilastatin 
     Meropenem 
J01DH51 
J01DH02 
3rd generation cephalosporins (with or without beta-lactamase inhibitor)  
     Cefixime J01DD08 
     Cefotaxime J01DD01 
     Ceftazidime J01DD02 
     Ceftriaxone  J01DD04 
Glycopeptides   
    Teicoplanin  J01XA02 
    Vancomycin  J01XA01 
Macrolides  
    Azithromycin J01FA10 
    Clarithromycin  J01FA09 
    Erythromycin  J01FA01 
Quinolones and fluoroquinolones   
    Ciprofloxacin  J01MA02 
    Levofloxacin  J01MA12 
Reserve antibiotics  ATC code 
Aztreonam J01DF01 
4th  generation cephalosporins: Cefepime J01DE01 
5th generation cephalosporins: Ceftaroline J01DI02 
Oxazolidinones: Linezolid J01XX08 
Daptomycin J01XX09 
Fosfomycin J01XX01 
Polymyxins: Colistin J01XB01 
                     Polymyxin B J01XB02 
Tigecycline J01AA12 
     











Supplementary Table 3. Description of participating countries by income* 
  
Country  WHO-region OECD 
member 
GARPEC PPS 
  Total no. hospitals Total no. prescriptions† 
High-income countries  
Australia Western Pacific Yes 4 423
Finland  Europe Yes 1 256
Greece  Europe Yes 5 506
Germany Europe Yes 5 624
Israel  Europe Yes 1 30
Italy  Europe Yes 4 851
Japan Western Pacific Yes 1 303
Poland Europe Yes 2 14
Singapore  Western Pacific No 1 89
Slovenia Europe Yes 1 189
Spain Europe Yes 2 316
Taiwan Western Pacific No 1 53
UK Europe Yes 12 2,277
USA Americas Yes 31 19340
Upper-middle income countries   
Argentina Americas No 1 83
Brazil Americas No 7 1133
China Western Pacific No 18 3788
South Africa  Africa No 2 606
Thailand SEA No 2 506
Turkey Europe Yes 1 24
Lower-middle income countries   
India SEA No 10 1000
Nigeria Africa No 2 156
Pakistan Eastern Mediterranean No 1 213
Low-income country   
Gambia Africa No 1 22
Country  WHO-region OECD 
member 
Global-PPS 
  Total no. hospitals Total no. prescriptions† 
High-income countries  
Australia Western Pacific Yes 3 93
Bahrain Eastern Mediterranean No 1 104
Belgium  Europe Yes                  60 473
Canada  Americas Yes 7 93
Chile  Americas Yes 3 123
Croatia  Europe No 3 14
Finland  Europe Yes 1 10
France  Europe Yes 1 4
Greece  Europe Yes 1 119
Germany Europe Yes 2 95
Ireland Europe Yes 2 58
Italy  Europe Yes 2 88
Japan Western Pacific Yes 13 287
South Korea Western Pacific Yes 1 11
Latvia Europe Yes 2 148
Lithuania Europe Yes 1 82
Malta Europe No 1 25
Netherlands Europe Yes 1 3
New Zealand Western Pacific Yes 1 3
Saudi Arabia Eastern Mediterranean No 1 162
Singapore  Western Pacific No 2 49
Slovenia Europe Yes 1 70
Spain Europe Yes 1 18
Switzerland  Europe Yes 1 25
UK Europe Yes 14 595
USA Americas Yes 10 241
Upper-middle income countries   
Albania Europe No 6 265
Argentina Americas No 4 41
Bosnia and Herzegovina Europe No 2 94
Brazil Americas No 1 40
China Western Pacific No 1 62
Costa Rica Americas No 2 14
Guinea Africa No 1 63
Georgia Europe No 3 66
Jordan Eastern Mediterranean No 2 22
Iran Eastern Mediterranean No 3 282
Iraq Eastern Mediterranean No 3 232
FYROM (Macedonia) Europe No 4 178
Mexico Americas No 1 693
Montenegro  Europe No 5 98
Russian Federation Europe No 5 325
Serbia  Europe No 4 210
South Africa  Africa No 1 179
Lower-middle income countries   
Armenia Europe No 2 114
Ghana Africa No 1 71
Kosovo‡ Europe No 6 190
Kyrgyzstan Europe No 2 298
Nigeria Africa No 4 288
 
Abbreviations: SEA, South-East Asia; OECD, the Organisation for Economic Cooperation and Development. * World Bank Country and Leading groups 
(https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups). † Total number of antibiotic prescriptions under WHO ATC 
code: J01. ‡Kosovo (in accordance with UN Security Council resolution 1244 [1999]) 
